Browsing: FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment

The U.S. FDA recently approved ALPHA-1062 (Zunveyl®) by Alpha Cognition Inc. for treating mild-to-moderate Alzheimer’s disease, which affects 6.7 million…